Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

JPH reports net income of $1.19 million in Q1 2018

2018-04-30

According to the financial statements of Jerusalem Pharmaceuticals JPH for the quarter of 2018, Net profit after tax of the period reached 1,188,800 USD Compared with Net profit after tax 1,605,998 USD for 2017, a net decrease in profit of 25.98%.Total assets of the company reached 62,652,758 USD compared with total assets of 61,625,755 USD at the end of year 2017, a net increase of 1.67%.Total liabilities of the company reached 12,109,427 USD compared with total liabilities of 12,237,751 USD at the end of year 2017, a net decrease of 1.04%. Net ownership equity of the company reached 50,543,331 USD (Including Non-Controlling Interests of 842,333 USD) compared with total owner equity of 49,388,004 USD (Including Non-Controlling Interests of 851,077 USD) at the end of year 2017, a net increase of 2.34%.

 


 

2021-10-26
RSR posts net income of JD0.31 million in 9M 2021

2021-10-26
APC records net income of JD0.82 million in 9M 2021

2021-10-24
ARAB posts net income of JD0.02 million in 9M 2021

2021-10-21
Al-Quds Index in a narrow range amid an increase in 9M financial data disclosures anticipation

2021-10-17
PHARMACARE recommends distributing 10% cash dividends for the year 2020

2021-10-14
A transaction on the stocks of TRSUT raises the trading value in the PEX

2021-10-07
Al-Quds Index rebounds upwards in the first week of October

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013